MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17582024.2026.2681564

Медицинская библиотека · Neurodegenerative disease management · 2026

Bright light therapy for depression and excessive daytime sleepiness in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials with dose-response meta-regression.

Messak Mark, Abdelmageed Ahmed, Khattab Youssef A, Mandour Youssef, Shaker Omar, Negida Ahmed

СтатьяОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND

Non-motor symptoms, including depression and excessive daytime sleepiness (EDS), reduce quality of life in Parkinson's disease (PD). Pharmacological treatments may cause side-effects, highlighting the need for non-pharmacological approaches. We conducted an updated meta-analysis with linear and non-linear dose-response meta-regression to evaluate bright light therapy (BLT) on depression and EDS in PD.

METHODS

PubMed, Scopus, and WOS were systematically searched through September 2025. Risk of bias was assessed using RoB-2 and NIH single-arm tools. Mean difference (MD) or standardized mean difference (SMD) with 95%confidence intervals (CI) were pooled using fixed-effects models. Linear and non-linear dose-response meta-regressions were performed.

RESULTS

Eight studies were identified, six included in meta-analysis. For EDS, five studies (n = 159) showed no significant effect of BLT (MD =-1.14, 95%CI [-2.43, 0.15], p = 0.083, I2 = 0%), with no linear (p = 0.78) or non-linear (p = 0.97) dose-response relationship. For depression, five studies (n = 194) also showed no significant effect (SMD =-0.13, 95%CI [-0.41, 0.16], p = 0.38, I2 = 0%), without linear (p = 0.82) or non-linear (p = 0.85) associations. Sensitivity analyses were consistent.

CONCLUSION

BLT was not associated with significant improvement in depression or EDS in PD, and no dose-response relationship was identified. Given methodological limitations, BLT cannot currently be recommended for clinical use. Future standardized dose-finding trials stratified by disease stage and retinal/ipRGC integrity are needed.

Для цитирования: Messak Mark, Abdelmageed Ahmed, Khattab Youssef A, Mandour Youssef, Shaker Omar, Negida Ahmed. Bright light therapy for depression and excessive daytime sleepiness in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials with dose-response meta-regression.. Neurodegenerative disease management. 2026. DOI: 10.1080/17582024.2026.2681564.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.